5962T <-- Y. Kosako 85002 <-- Nissui Pharm. Co., Ltd. <-- ATCC 10145 <-- F. Kavanagh <-- Merck Sharp & Dohme Res. Labs. Accessioned in 1986. =ATCC 10145 =BCRC 10944 =CCEB 481 =CCM 1960 =CCUG 551 =CCUG 28447 =CECT 110 =CGMCC 1.1785 =CIP 100720 =DSM 50071 =IAM 1514 =IFO 3756 =IFO 12689 =KCTC 1750 =LMG 1242 =NBRC 3756 =NBRC 12689 =NCDO 1369 =NCIMB 8295 =NCPPB 1965 =NCTC 10332 =NRRL B-771. Type strain [2027]. Medium: 12, 22; Temperature: 37°C; Rehydration fluid: 663. |
![]() open link in new window |
![]() open link in new window |
Biosafety level | 2 | ||
Terms and conditions | Not applicable | - | |
Export control (1) | No | - | |
Distribution control in Japan (2) | No | - | |
Genetically modified microorganism | No | - | |
Technical information | - | - | |
Additional information | - | - |
Domestic | A (Freeze-dried or L-dried culture) or C (Actively growing culture on request) | |
Overseas | A (Freeze-dried or L-dried culture) or C (Actively growing culture on request) |